The Stop TB Partnership, aiming to increase attention about TB with the general population, launches awareness efforts at the heart of New York City at Times Square.

Researchers at Washington University School of Medicine in St. Louis have discovered a molecule in the lungs of tuberculosis (TB) patients that reflects the levels of TB-causing bacteria in the lungs, information needed to better address the notoriously difficult to treat disease.

RESIST-TB released its January 2022 newsletter with the latest research publications on drug-resistant TB.

Can patents affect access to TB preventive treatment? - a community guidebook, produced by the ARK Foundation of Nagaland, India

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

28 January 2022 | Geneva: Following review of  evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beijing Wantai’s TB-IGRA and Qiagen QuantiFERON-TB Gold Plus products. This expands the range of tests available to detect TB infection. Full details are provided in the WHO policy statement.

A new vaccine against tuberculosis may also be used as treatment. The vaccine is safe to give to people with tuberculosis disease and strengthens the immune system's ability to attack the bacteria that cause the disease, a new study shows.

According to the WHO, a total of 1.5 million people died from tuberculosis (TB) in 2020. It is second only to COVID-19 as a leading cause of death as a result of an infectious disease, with over 95% of cases and deaths occurring in developing countries.

Statement on 2021 G-FINDER Report